Total planned funding: $284,076,977
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Mozambique | $61,336,189 |
Nigeria | $43,150,813 |
Zambia | $36,058,041 |
Tanzania | $20,991,259 |
Kenya | $20,495,118 |
Burundi | $12,663,443 |
Vietnam | $8,697,504 |
Indonesia | $8,406,590 |
Botswana | $8,389,397 |
Côte d'Ivoire | $5,963,330 |
Rwanda | $5,586,437 |
Haiti | $5,520,713 |
South Africa | $5,409,615 |
India | $5,323,000 |
Cambodia | $4,700,000 |
South Sudan | $4,481,916 |
Asia Regional Program | $3,654,954 |
Papua New Guinea | $3,189,171 |
Democratic Republic of the Congo | $3,140,000 |
Ethiopia | $3,038,597 |
Caribbean Region | $2,717,206 |
Malawi | $2,610,000 |
Central America Region | $1,646,143 |
Uganda | $1,468,804 |
Ghana | $1,290,000 |
Angola | $1,085,000 |
China | $850,000 |
Cameroon | $700,000 |
Eswatini | $513,737 |
Dominican Republic | $500,000 |
Central Asia Region | $300,000 |
Thailand | $200,000 |
Lesotho | $0 |
Organizational Types
NGO | $276,425,540 |
Implementing Agency | $7,651,437 |
Program Areas
Care | $93,401,722 |
Prevention | $88,345,221 |
Treatment | $61,848,795 |
Testing | $21,017,436 |
Governance and Systems | $19,463,803 |
Budget Codes
HTXS: Treatment: Adult Treatment | $55,690,919 |
HBHC: Care: Adult Care and Support | $43,404,702 |
HVOP: Sexual Prevention: Other Sexual Prevention | $35,997,555 |
HKID: Care: Orphans and Vulnerable Children | $33,527,990 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $31,727,579 |
HVCT: Testing: HIV Testing and Counseling | $21,017,436 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $10,050,208 |
HVTB: Care: TB/HIV | $9,082,092 |
HVSI: Strategic Information | $7,520,200 |
OHSS: Health Systems Strengthening | $7,487,712 |
PDCS: Care: Pediatric Care and Support | $7,386,938 |
PDTX: Treatment: Pediatric Treatment | $6,157,876 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $5,636,093 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $4,573,347 |
HLAB: Laboratory Infrastructure | $4,455,891 |
HMIN: Biomedical Prevention: Injection Safety | $288,291 |
HMBL: Biomedical Prevention: Blood Safety | $72,148 |